155 related articles for article (PubMed ID: 35456397)
81. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.
Martínez P; Sánchez-Vázquez R; Ferrara-Romeo I; Serrano R; Flores JM; Blasco MA
PLoS Genet; 2022 Jun; 18(6):e1010260. PubMed ID: 35727838
[TBL] [Abstract][Full Text] [Related]
82. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
83. MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence.
Li T; Luo Z; Lin S; Li C; Dai S; Wang H; Huang J; Ma W; Songyang Z; Huang Y
Aging (Albany NY); 2020 Jul; 12(14):14791-14807. PubMed ID: 32687062
[TBL] [Abstract][Full Text] [Related]
84. Comparative study of marginal zone lymphoma involving bone marrow.
Kent SA; Variakojis D; Peterson LC
Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
[TBL] [Abstract][Full Text] [Related]
85. Murine Models of Splenic Marginal Zone Lymphoma: A Role for
Patten CL; Cutucache CE
Front Oncol; 2016; 6():258. PubMed ID: 28018857
[TBL] [Abstract][Full Text] [Related]
86. Loss-of-function variants in
Nathan V; Palmer JM; Johansson PA; Hamilton HR; Warrier SK; Glasson W; McGrath LA; Kahl VFS; Vasireddy RS; Pickett HA; Brooks KM; Pritchard AL; Hayward NK
J Med Genet; 2021 Apr; 58(4):234-236. PubMed ID: 32907878
[No Abstract] [Full Text] [Related]
87. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
[No Abstract] [Full Text] [Related]
88. Human shelterin protein POT1 prevents severe telomere instability induced by homology-directed DNA repair.
Glousker G; Briod AS; Quadroni M; Lingner J
EMBO J; 2020 Dec; 39(23):e104500. PubMed ID: 33073402
[TBL] [Abstract][Full Text] [Related]
89. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.
Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; Nakayama H; Yasui W
Cancer Res; 2004 Jan; 64(2):523-9. PubMed ID: 14744765
[TBL] [Abstract][Full Text] [Related]
90. Germline POT1 mutation and neuroblastoma: A mere coincidence or true association.
Legrand C; Peysselon M; Bidart M; Bouras A
Pediatr Blood Cancer; 2024 Jul; 71(7):e31054. PubMed ID: 38706191
[No Abstract] [Full Text] [Related]
91. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
92. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones.
Lefebvre C; Fabre B; Vettier C; Rabin L; Florin A; Wang J; Gressin R; Jacob MC; Callanan M; Leroux D
Hum Pathol; 2007 Apr; 38(4):660-7. PubMed ID: 17134739
[TBL] [Abstract][Full Text] [Related]
93. Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant?
Lloret E; Mollejo M; Mateo MS; Villuendas R; Algara P; Martínez P; Piris MA
Hum Pathol; 1999 Oct; 30(10):1153-60. PubMed ID: 10534161
[TBL] [Abstract][Full Text] [Related]
94. A germline exome analysis reveals harmful
Hakkarainen M; Koski JR; Heckman CA; Anttila P; Silvennoinen R; Lievonen J; Kilpivaara O; Wartiovaara-Kautto U
EJHaem; 2022 Nov; 3(4):1352-1357. PubMed ID: 36467798
[TBL] [Abstract][Full Text] [Related]
95. Heritable defects in telomere and mitotic function selectively predispose to sarcomas.
Ballinger ML; Pattnaik S; Mundra PA; Zaheed M; Rath E; Priestley P; Baber J; Ray-Coquard I; Isambert N; Causeret S; van der Graaf WTA; Puri A; Duffaud F; Le Cesne A; Seddon B; Chandrasekar C; Schiffman JD; Brohl AS; James PA; Kurtz JE; Penel N; Myklebost O; Meza-Zepeda LA; Pickett H; Kansara M; Waddell N; Kondrashova O; Pearson JV; Barbour AP; Li S; Nguyen TL; Fatkin D; Graham RM; Giannoulatou E; Green MJ; Kaplan W; Ravishankar S; Copty J; Powell JE; Cuppen E; van Eijk K; Veldink J; Ahn JH; Kim JE; Randall RL; Tucker K; Judson I; Sarin R; Ludwig T; Genin E; Deleuze JF; ; Haber M; Marshall G; Cairns MJ; Blay JY; ; Thomas DM; Tattersall M; Neuhaus S; Lewis C; Tucker K; Carey-Smith R; Wood D; Porceddu S; Dickinson I; Thorne H; James P; Ray-Coquard I; Blay JY; Cassier P; Le Cesne A; Duffaud F; Penel N; Isambert N; Kurtz JE; Puri A; Sarin R; Ahn JH; Kim JE; Ward I; Judson I; van der Graaf W; Seddon B; Chandrasekar C; Rickar R; Hennig I; Schiffman J; Randall RL; Silvestri A; Zaratzian A; Tayao M; Walwyn K; Niedermayr E; Mang D; Clark R; Thorpe T; MacDonald J; Riddell K; Mar J; Fennelly V; Wicht A; Zielony B; Galligan E; Glavich G; Stoeckert J; Williams L; Djandjgava L; Buettner I; Osinki C; Stephens S; Rogasik M; Bouclier L; Girodet M; Charreton A; Fayet Y; Crasto S; Sandupatla B; Yoon Y; Je N; Thompson L; Fowler T; Johnson B; Petrikova G; Hambridge T; Hutchins A; Bottero D; Scanlon D; Stokes-Denson J; Génin E; Campion D; Dartigues JF; Deleuze JF; Lambert JC; Redon R; Ludwig T; Grenier-Boley B; Letort S; Lindenbaum P; Meyer V; Quenez O; Dina C; Bellenguez C; Le Clézio CC; Giemza J; Chatel S; Férec C; Le Marec H; Letenneur L; Nicolas G; Rouault K
Science; 2023 Jan; 379(6629):253-260. PubMed ID: 36656928
[TBL] [Abstract][Full Text] [Related]
96. Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders.
DeRoin L; Cavalcante de Andrade Silva M; Petras K; Arndt K; Phillips N; Wanjari P; Subramanian HP; Montes D; McElherne J; Theissen M; Briese R; Das S; Godley LA; Segal J; Del Gaudio D; Fitzpatrick C; Churpek JE
Hum Mutat; 2022 Jul; 43(7):950-962. PubMed ID: 35419889
[TBL] [Abstract][Full Text] [Related]
97. Variant ranking pipeline for complex familial disorders.
Ralli S; Vira T; Robles-Espinoza CD; Adams DJ; Brooks-Wilson AR
Sci Rep; 2024 Jun; 14(1):13599. PubMed ID: 38866901
[TBL] [Abstract][Full Text] [Related]
98. Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms.
Calvete O; Mestre J; Risueño RM; Manzanares A; Acha P; Xicoy B; Solé F
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137443
[TBL] [Abstract][Full Text] [Related]
99.
Fanelli A; Marconato L; Licenziato L; Minoli L; Rouquet N; Aresu L
Front Vet Sci; 2022; 9():968807. PubMed ID: 36016811
[TBL] [Abstract][Full Text] [Related]
100. Atypical CD5 and CD10 coexpression in a splenic marginal zone lymphoma.
Gimenez De Mestral S; Delhommeau F; Fabiani B; Cervera P; Suner L
EJHaem; 2021 May; 2(2):307-308. PubMed ID: 35845281
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
